MALDI-TOF
Agena Bioscience Expands Into South America With Distribution Deals in Argentina, Brazil
EXSA SRL will distribute Agena's products throughout Argentina and Uniscience do Brasil will do the same in the Brazilian market.
BioMérieux Gets FDA 510(k) Clearance for MALDI-TOF Bacterial ID System
The next-generation system, which received CE marking last year, identifies bacteria more rapidly and is now commercially available in the US.
MALDI-TOF Mass Spec Approach Can Predict Antimicrobial Resistance in Clinical Samples
A Swiss team said the mass spectrometry- and machine learning-based approach could help guide clinical treatment choices.
Agena Bioscience Gets FDA Emergency Use Authorization for MassArray Coronavirus Test
The company's RT-PCR/MALDI-TOF test comprises five assays designed to detect the N, ORF1, and ORF1ab regions of the SARS-CoV-2 genome.
With the exception of Thermo Fisher Scientific, which released three new instruments, vendors focused mainly on expanded applications of existing platforms.
Feb 25, 2016
Jan 15, 2016
May 14, 2015
Jan 28, 2013
Ezose Sciences, Kyowa Hakko Ink Glycomics Pact
Jan 3, 2013
Bruker Licenses IP from Erasmus Medical Center
Dec 9, 2011
Aug 26, 2011
Aug 19, 2011
May 6, 2011
Apr 8, 2011